Heron Therapeutics: Q2 Earnings Snapshot
SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Tuesday reported a loss of $56.4 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 55 cents.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.
The pharmaceutical company posted revenue of $27.6 million in the period.